medical-device-investing Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System
medical-device-investing Obalon Therapeutics Inc Announces Fourth Quarter and Year End 2016 Financial Results Conference Call
medical-device-investing Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss
Torrent Capital Reports Preliminary Q4 and Year-End 2025 Financial Results and Net Asset Value Update
Intercontinental Exchange CFO Warren Gardiner to Present at the UBS Financial Services Conference on February 9